Dr. Lal PathLabs Launches Sovaaka Wellness Centre in Gurugram
Filing Summary
Dr. Lal PathLabs Limited has launched Sovaaka, a new Diagnostic Experience Centre in Gurugram, on January 6, 2026. Sovaaka offers personalized diagnostics-led wellness programs, including Eterna for women and Vita for men, tailored to individual needs. The centre features advanced diagnostics such as high-sensitivity blood panels, genetic testing, and AI-supported imaging. Equipped with low-dose CT, 1.5T MRI, and DEXA scanning, Sovaaka aims to provide comprehensive health evaluations. This launch aligns with the growing preventive health and wellness segment in India.
On January 6, 2026, Dr. Lal PathLabs Limited announced the launch of Sovaaka, a new Diagnostic Experience Centre located in Gurugram. The centre is designed to offer a personalized diagnostics-led wellness experience, focusing on preventive and lifestyle healthcare.
Sovaaka introduces programs such as Eterna for women and Vita for men, which are customized based on age, gender, and lifestyle. The centre integrates advanced diagnostics, including high-sensitivity blood panels, genetic testing, and AI-supported imaging, with digital health records for a comprehensive health evaluation.
The facility is equipped with low-dose CT, 1.5T MRI, DEXA scanning, and a wide range of routine and advanced blood tests. These resources ensure fast turnaround times and provide detailed insights into an individual’s health. The centre also offers end-to-end clinical report evaluation and tailored nutrition guidance.
The launch of Sovaaka comes amid a rise in the preventive health and wellness segment in India, driven by increasing cases of Non-Communicable Diseases and a growing emphasis on early detection. This initiative by Dr. Lal PathLabs aims to address these trends by offering evidence-backed solutions for better health understanding and proactive management.
Dr. Lal PathLabs is a provider of diagnostic and related healthcare tests and services in India. The company operates an integrated, nationwide network offering a broad range of medical diagnostic tests and services for patient diagnosis, prevention, monitoring, and treatment. As of March 31, 2025, it has over 298 clinical laboratories, including a National Reference Lab in Delhi, and more than 6,607 Patient Service Centres and 12,365 Pick-up Points. Its customers include individual patients, hospitals, healthcare providers, and corporate clients.